Saad I. Mallah (@SaadIMallah) header
Saad I. Mallah (@SaadIMallah) profile picture

Surgery Resident @loyolasurgery, @MayoAZSurg | Ex-Junior Doctor @NHSBartsHealth | Vascular & SCC Aspirant🩸| Global Surgery Devotee | @RCSI_Bahrain

Chicago, IL
Joined January 2021
Photo by Saad I. Mallah (@SaadIMallah)Photo by Saad I. Mallah (@SaadIMallah)Photo by Saad I. Mallah (@SaadIMallah)Photo by Saad I. Mallah (@SaadIMallah)Photo by Saad I. Mallah (@SaadIMallah)Photo by Saad I. Mallah (@SaadIMallah)Photo by Saad I. Mallah (@SaadIMallah)Photo by Saad I. Mallah (@SaadIMallah)Photo by Saad I. Mallah (@SaadIMallah)Photo by Saad I. Mallah (@SaadIMallah)
The OR can be an intimidating place for med students. Especially when they're on away electives or are visiting internationally. Following a steep learning curve, here is my best attempt at formulating a brief guidance manual: How to Navigate the OR as a Student - A 🧵 (1/14)
5
6
1
53
26,674
A good time with great company at this year's @MWVSSociety 50th anniversary! Featuring @CookMedical's aortic aneurysm planning & sizing workshop, and of course—team @LoyolaVascular!
1
5
403
I know we like to complain about 24hr shifts, and maybe this is just 'post-shift bliss' talking, but the fact that we can pull them off routinely, taking care of critical patients through the night, is a developed skill we do not give ourselves enough credit for as a profession.
4
2
12
4,152
When the intern asks about endoleaks so you whip out the drawing board 🎨
1
5
354
Do MIs/strokes only matter if they cause mortality or permanent disability? Is the significant impact they have on an elderly person's mental health, pain, stress, time, finances etc., not of real value even if unquantified?
9 years of statin No significant effect on all-cause mortality No improvement in overall disability We need stewards of lipid medications and not people who ignore standard-of-care BEERS criteria
2
1
4
867
Have the ppl criticising lack of mortality benefit despite reduction in number of CV events considered that this was due to great access & advancements in ACS/CVA care? What if the study was replicated in a less-resourceful population where this care was not as readily available?
Presented at #ESCCongress: In older adults without cardiovascular disease, treatment with atorvastatin led to a lower risk of major cardiovascular events than placebo at a median of 5.9 years but did not result in longer disability-free survival. Full STAREE trial results: nej.md/4ghHPSC @escardio
1
1
399
Plus, do MIs/strokes only matter if they cause mortality or permanent disability? Is the impact they have on an elderly person's mental state, pain, time, money etc. not of real value even if unquantified?
66
Saad I. Mallah retweeted
There’s a point mid surgery when as a medical student you’re standing there, usually retracting some skin flap, organ or guts, and out of nowhere the gravity of just what it is you’re doing hits you and you stand in utter awe We’re really not playing games here. It is truly life and death, and as the doctor you’re standing there wielding cutting edge modern technology and millennia old surgical knowledge passed down from centuries, making sure the balance scale for this person laid bare in front of you leans towards life. It is utter insanity, yet we do it daily, and usually successfully. There is simply no way you can be standing in an OR mid surgery, thinking anything else could be even remotely as important and awe inspiring.
I’m enjoying medicine and especially the OR so much I’m realizing I might actually be completely content never thinking about business and tech ever again Insane development in my arc
2
2
36
12,943
Every room should be beautified by a drawing of the Aorta 🩸
1
4
445
Saad I. Mallah retweeted
Replying to @MattZirwas
The thing about AI evolving is that so will our capabilities as a species. You may have trained it to reason through a complex case and its black box warning, but this will only introduce novel meds, complications, cases etc. that will also need us to help it reason through.
2
1
1
210
Discourse on AI replacing medical workforce is centered around clinic & primary care where it already is playing a role. That is quite different than the OR, angio suits, ICU, trauma bay, etc. which is the bulk of our work & yet not what the public (thankfully) is most exposed to
Yesterday I spent an hour with a man in his eighties who has one cancer spot, in his brain, in the speech area. He can barely get words out now. He wants to stay alive because his wife is sick and he is the one who takes care of her. He does not want chemotherapy because he remembers what it did to him last time. His family wants everything done. Tell me which model solves that. I read the JAMA Perspective arguing that autonomous AI will exceed AI aided physicians. The numbers in it are real and I am not here to dispute them. But two things are worth saying plainly. It is a Perspective, not a trial. And it went viral in large part because of whose name is on it. Put Khosla on almost anything about AI replacing doctors and it travels. Here is the part I want to argue with instead. The paper measures medicine as diagnosis and decision making. That is maybe ten percent of my day. The other ninety percent is not in the literature at all. Another patient this week, heavy smoking history, previous pancreatic cancer removed surgically, now new spots in the lungs. Could be lung. Could be pancreatic. We ran the full genetic workup and we still do not know. He and I have to decide anyway. There is no paper for that. A third has had bladder cancer and breast cancer. Every trial I would want for her excludes her, because a second primary disqualifies you. The evidence base was not built with her in it. So when we say AI selects "the most appropriate treatment," I want to ask who defined appropriate. It was defined by prior literature and prior trials. Trials that excluded my patient. Trials with their own biases baked in. Sometimes the right move is a less appropriate treatment, because it is the one that fits the life the person actually wants to live. The patient decides that, not the guideline. And I should be clear: if AI takes this part of my job, I am fine with it. I am not defending my job. It is heavy to deliver prognosis all day. I love this work and I am already moving toward machine learning because I want to work on curing cancer rather than only treating it. What I actually wonder about is behavior, not capability. When Airbnb started, the idea that you would let a stranger sleep in your house sounded insane. It changed because people got paid. The money moved the behavior. Health has no equivalent lever. Patients already come to me having asked ChatGPT, and I encourage that. Then they sit down and we talk anyway. Because what they came for was not the answer. It was to be helped to decide, by someone who will still be there when the decision goes badly. I do not know what changes that. Maybe something does. But the paper is about accuracy, and the thing standing between these tools and my exam room is not accuracy.
1
2
597
Saad I. Mallah retweeted
Updated the AAA Planning Tool to include EVAR, TEVAR, & FEVAR, plus an AAA repair risk calculator. This version now incorporates costs & complexity for each device, and separate labelling for devices that can be within IFU if used with adjuncts (e.g., Heli-FX EndoAnchors). Link:
1
2
6
565
Saad I. Mallah retweeted
Created an EVAR planning and compliance app that compares aneurysm dimensions, aortic anatomy, & access site limitations against manufacturer manuals (IFUs) & outcomes literature for different commercial infrarenal endografts w/ colleague @Alalshawi and AI saadevarplanning.netlify.app…
1
3
8
760
Updated the AAA Planning Tool to include EVAR, TEVAR, & FEVAR, plus an AAA repair risk calculator. This version now incorporates costs & complexity for each device, and separate labelling for devices that can be within IFU if used with adjuncts (e.g., Heli-FX EndoAnchors). Link:
1
2
6
565
Saad I. Mallah retweeted
Replying to @Bibimboppoo
Long ago, one of my attendings told me that you could do these big operations in sick people, but if you can’t get them through the rest of it, then in fact, you really can’t do big operations in sick people. So it’s all part of it. 🤷‍♂️
9
2
3
88
17,294
Created an EVAR planning and compliance app that compares aneurysm dimensions, aortic anatomy, & access site limitations against manufacturer manuals (IFUs) & outcomes literature for different commercial infrarenal endografts w/ colleague @Alalshawi and AI saadevarplanning.netlify.app…
1
3
8
760
Clinically, this would be more of an educational tool for residents but would love feedback on this from surgeons and device reps on how to make it more clinically useful! @GAEscobarMD @farkomd @AWBeckMD @AlanLumsdenMD @@JamesHBlackMD @NextGenVascular @westleyohman @zwanken
151
After struggling to find a doppler, I was pleasantly surprised to be presented with this now-obsolete "doppler stethescope" from the 1980s...I must confess, the audio output had less noise and more clarity than any of the modern ones! Does anyone still use these?
3
13
834
Topical hemostatic agents come in all forms and mechanisms—below is my best attempt at categorising them. Will have to eventually write a comprehensive review on this!
1
3
346
"To allow yourself to be moved by other's suffering, & to give yourself away in the service of caring for these people...while we will sometimes fall short of the ideal, we must remain dedicated to working towards it"—beautiful shared values talk from orientation at @LoyolaHealth
5
360